Zobrazeno 71 - 80
of 303
pro vyhledávání: '"Benoit You"'
Autor:
Lone Sunde, Kirsty Balanchandran, Minke Frijstein, Georgia Mangili, Sileny Han, Miguel Henriques Abreu, Nataliya Tsip, Anneke M. Westermann, Vilmos Fulop, Franziska Siegenthaler, Michael J. Seckl, Manuela Undurraga, John Coulter, Anne Hills, Angela Salerno, Kamaljit Singh, Lotte Boog, Jacob Korach, Nelleke Ottevanger, Jérôme Massardier, Ulrika Joneborg, Eva Maria Roes, Frédéric Goffin, Luisa Skupin, Fernando Manuel Ribeiro Gomes, Alice Bergamini, Jane Ireson, Benoit You, Catriona Kenneally, Miroslav Korbel, Saša Kadija, Vildana Finci, Isa Niemann, Sarah Delcominette, Antonio Casado, Gloria Marquina, Pierre Adrien Bolze, Grzegorz Szewczyk, François Golfier, Nienke E. van Trommel, Naveed Sarwar, Raffaella Cioffi, Cantù Maria Grazia, Patrick Chien, John Tidy, Christianne A.R. Lok, Gitta Turowski, Yalck K. Eysbouts, Su Harma, Ginette Rosseel, Ulrike Meyer-Hamme, Erika Utracka, Jocelyne Attia, Mehmet Harma, Olesya Solheim, Matthew C Winter, Jean Pierre Lotz, Vesna Kesic, Sophie Patrier, Muge Harma, Janne Kaern, Magdalena Miedzińska, Sinan Ozalp, Eva-Maria Grischke, Amit Mayer, Leigh Bowman, Emelie Wallin, Hind Hamad Elmalik, Leon F.A.G. Massuger
Publikováno v:
European Journal of Cancer, 130, pp. 228-240
European journal of cancer (Oxford, England, 130, 228-240. Elsevier Limited
European Journal of Cancer, 130, 228-240
European journal of cancer (Oxford, England, 130, 228-240. Elsevier Limited
European Journal of Cancer, 130, 228-240
Background and aim Gestational trophoblastic disease (GTD) is a heterogeneous group of disorders characterised by abnormal proliferation of trophoblastic tissue. Since GTD and its malignant sequel gestational trophoblastic neoplasia (GTN) are rare di
Autor:
Michel Tod, Benoit You, Christian Kurzeder, Jacobus Pfisterer, Julien Péron, Alexandra Leary, Gilles Freyer, Anne-Claire Hardy-Bessard, Andreas du Bois, Alexander Burges, Olivier Colomban, Isabelle Ray-Coquard, Alain Lortholary
Publikováno v:
Clinical Cancer Research. 25:5342-5350
Purpose: Regarding cancer antigen 125 (CA-125) longitudinal kinetics during chemotherapy, the actual predictive value of the Gynecologic Cancer Intergroup (GCIG) CA-125 response criterion is questioned. The modeled CA-125 elimination rate constant KE
Autor:
Benoit, You, Eric, Assenat, Léa, Payen, Thibault, Mazard, Olivier, Glehen, Sara, Calattini, Laurent, Villeneuve, Gaëlle, Lescuyer, Bérengère, Vire, Marc, Ychou
Publikováno v:
Bulletin du cancer. 109(6)
Recent technological advances coupled with our improved understanding of the molecular and cellular mechanisms associated with cancer development have enabled better overall patient care. Among the newly identified biomarkers such as circulating tumo
Autor:
Linda R. Duska, Y. Xiang, M Puglisi, Benoit You, M-R Christiaens, A Oaknin, D Lorusso, Robert L. Coleman, J Sehouli, Leslie M Randall, M Mirza, C Marth, Cagatay Taskiran, David Cibula, Sandro Pignata, Angélica Nogueira-Rodrigues, K Yamada, N Colombo, Jacob Korach, Kosei Hasegawa
Publikováno v:
E-Posters.
Autor:
S Moret, M. Leheurteur, Annick Chevalier-Place, L. Venat-Bouvet, Philippe Follana, Alexandra Leary, Jean-Pierre Lotz, Laure Favier, Sophie Abadie-Lacourtoisie, F Del Piano, Jérôme Meunier, C. Louvet, Benoit You, Anne Floquet, Olivier Colomban, G. De Rauglaudre, Pierre Combe, Carol Alliot, J Pierre-Alexandre, N. Raban
Publikováno v:
Translational research biomarkers.
Introduction/Background* As stated by ESGO-ESMO, there is a need for indicators of chemotherapy efficacy in ovarian carcinoma patients treated in first-line setting (Colombo et al, IGCS, 2020). The pathological chemotherapy response score (CRS) and t
Autor:
A Floquet, Gilles Freyer, Catherine Mercier, Benoit You, J. P. Lotz, J. Massardier, P Descargues, Adeline Roux, P. Rousset, D Grazziotin –soares, Carole Langlois-Jacques, P.-A. Bolze, L. Gladieff, François Golfier, T Hajri, Sylvie Bin, Marine Alves-Ferreira, Laurent Villeneuve
Publikováno v:
Trophoblastic diseases.
Introduction/Background* In patients with gestational trophoblastic tumors (GTT) with a FIGO score ≥ 7, or GTT resistant to both standard monotherapies, the recommended polychemotherapy regimen is EMA-CO. In case of resistance to polychemotherapy,
Autor:
K Yamada, Jacob Korach, Mirza, M-R Christiaens, Cagatay Taskiran, Sandro Pignata, Domenica Lorusso, Christian Marth, Leslie M Randall, N Colombo, Jalid Sehouli, David Cibula, Robert L. Coleman, Angélica Nogueira-Rodrigues, A Oaknin, Benoit You, Linda R. Duska, Y. Xiang, M Puglisi, Kosei Hasegawa
Publikováno v:
Cervical cancer.
Introduction/Background* High-risk locally advanced cervical cancer has a poor prognosis, and more than half of patients recur in 2 years. External beam radiotherapy (EBRT) with concurrent chemotherapy followed by brachytherapy is the standard of car
Publikováno v:
Annals of surgical oncology. 29(3)
Autor:
Thibaut Reverdy, Solene De Talhouet, Gilles Freyer, Christophe Sajous, Benoit You, Julien Péron, Romain Varnier, Colette Smentek
Publikováno v:
Cancers
Cancers, Vol 13, Iss 4840, p 4840 (2021)
Cancers, Vol 13, Iss 4840, p 4840 (2021)
Simple Summary Gene expression signatures were initially developed to take into account tumor biology for adjuvant chemotherapy decision and have become a standard option in hormone receptors-positive/HER2-negative early breast cancer. While recent r
Autor:
Vahan, Kepenekian, Julien, Péron, Benoit, You, Isabelle, Bonnefoy, Laurent, Villeneuve, Mohammad, Alyami, Naoual, Bakrin, Pascal, Rousset, Nazim, Benzerdjeb, Olivier, Glehen
Publikováno v:
Annals of surgical oncology. 29(3)
Diffuse malignant peritoneal mesothelioma (DMPM) is an aggressive primary peritoneal neoplasia. At diagnosis, few patients are eligible for a recommended cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Among neoadju